Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01 (Q80970849)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 September 2007
edit
Language Label Description Also known as
English
Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01
scientific article published on 01 September 2007

    Statements

    title
    Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01 (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17761978
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17761978%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    4 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q80970849&oldid=2037709562"